404 related articles for article (PubMed ID: 25474204)
1. Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.
Lysenko LV; Kim J; Henry C; Tyrtyshnaia A; Kohnz RA; Madamba F; Simon GM; Kleschevnikova NE; Nomura DK; Ezekowitz RA; Kleschevnikov AM
PLoS One; 2014; 9(12):e114521. PubMed ID: 25474204
[TBL] [Abstract][Full Text] [Related]
2. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease.
Hashem J; Hu M; Zhang J; Gao F; Chen C
Mol Neurobiol; 2021 Aug; 58(8):4122-4133. PubMed ID: 33939165
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
Sciolino NR; Zhou W; Hohmann AG
Pharmacol Res; 2011 Sep; 64(3):226-34. PubMed ID: 21600985
[TBL] [Abstract][Full Text] [Related]
5. Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity.
Zhang Z; Wang W; Zhong P; Liu SJ; Long JZ; Zhao L; Gao HQ; Cravatt BF; Liu QS
Hippocampus; 2015 Jan; 25(1):16-26. PubMed ID: 25131612
[TBL] [Abstract][Full Text] [Related]
6. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.
Ignatowska-Jankowska B; Wilkerson JL; Mustafa M; Abdullah R; Niphakis M; Wiley JL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2015 May; 353(2):424-32. PubMed ID: 25762694
[TBL] [Abstract][Full Text] [Related]
7. Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2.
Martínez-Torres S; Cutando L; Pastor A; Kato A; Sakimura K; de la Torre R; Valjent E; Maldonado R; Kano M; Ozaita A
Brain Behav Immun; 2019 Oct; 81():399-409. PubMed ID: 31251974
[TBL] [Abstract][Full Text] [Related]
8. Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.
Zhang J; Chen C
Mol Neurobiol; 2018 Jun; 55(6):4802-4810. PubMed ID: 28733897
[TBL] [Abstract][Full Text] [Related]
9. The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB
Prüser JL; Ramer R; Wittig F; Ivanov I; Merkord J; Hinz B
Mol Cancer Ther; 2021 May; 20(5):787-802. PubMed ID: 33632876
[TBL] [Abstract][Full Text] [Related]
10. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
11. Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model.
Fernández-Suárez D; Celorrio M; Riezu-Boj JI; Ugarte A; Pacheco R; González H; Oyarzabal J; Hillard CJ; Franco R; Aymerich MS
Neurobiol Aging; 2014 Nov; 35(11):2603-2616. PubMed ID: 24973119
[TBL] [Abstract][Full Text] [Related]
12. The temporal dynamics of the effects of monoacylglycerol lipase blockade on locomotion, anxiety, and body temperature.
Aliczki M; Balogh Z; Tulogdi A; Haller J
Behav Pharmacol; 2012 Aug; 23(4):348-57. PubMed ID: 22750842
[TBL] [Abstract][Full Text] [Related]
13. Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells.
Pihlaja R; Takkinen J; Eskola O; Vasara J; López-Picón FR; Haaparanta-Solin M; Rinne JO
J Neuroinflammation; 2015 Apr; 12():81. PubMed ID: 25927213
[TBL] [Abstract][Full Text] [Related]
14. Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice.
Costola-de-Souza C; Ribeiro A; Ferraz-de-Paula V; Calefi AS; Aloia TP; Gimenes-Júnior JA; de Almeida VI; Pinheiro ML; Palermo-Neto J
PLoS One; 2013; 8(10):e77706. PubMed ID: 24204926
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice.
Crowe MS; Leishman E; Banks ML; Gujjar R; Mahadevan A; Bradshaw HB; Kinsey SG
Br J Pharmacol; 2015 Apr; 172(7):1700-12. PubMed ID: 25393148
[TBL] [Abstract][Full Text] [Related]
16. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
[TBL] [Abstract][Full Text] [Related]
17. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S
Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817
[TBL] [Abstract][Full Text] [Related]
19. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice.
Pan B; Wang W; Zhong P; Blankman JL; Cravatt BF; Liu QS
J Neurosci; 2011 Sep; 31(38):13420-30. PubMed ID: 21940435
[TBL] [Abstract][Full Text] [Related]
20. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.
Wiebelhaus JM; Grim TW; Owens RA; Lazenka MF; Sim-Selley LJ; Abdullah RA; Niphakis MJ; Vann RE; Cravatt BF; Wiley JL; Negus SS; Lichtman AH
J Pharmacol Exp Ther; 2015 Feb; 352(2):195-207. PubMed ID: 25398241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
